Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E.

Akhave N, Song Z, Hong DS, Gray RJ, Wang V, McShane LM, Rubinstein LV, Patton DR, Williams PM, Hamilton SR, Takebe N, Tricoli JV, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP, Flaherty KT

Open source

DOI: 10.1200/po-25-00612
Published: 2026 Feb
Container: JCO precision oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/po-25-00612,
  title = {Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E.},
  author = {Akhave N and Song Z and Hong DS and Gray RJ and Wang V and McShane LM and Rubinstein LV and Patton DR and Williams PM and Hamilton SR and Takebe N and Tricoli JV and Conley BA and Arteaga CL and Harris LN and O'Dwyer PJ and Chen AP and Flaherty KT},
  year = {2026},
  journal = {JCO precision oncology},
  doi = {10.1200/po-25-00612},
  url = {https://doi.org/10.1200/po-25-00612}
}

RIS

TY  - JOUR
TI  - Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E.
AU  - Akhave N
AU  - Song Z
AU  - Hong DS
AU  - Gray RJ
AU  - Wang V
AU  - McShane LM
AU  - Rubinstein LV
AU  - Patton DR
AU  - Williams PM
AU  - Hamilton SR
AU  - Takebe N
AU  - Tricoli JV
AU  - Conley BA
AU  - Arteaga CL
AU  - Harris LN
AU  - O'Dwyer PJ
AU  - Chen AP
AU  - Flaherty KT
PY  - 2026
JO  - JCO precision oncology
DO  - 10.1200/po-25-00612
UR  - https://doi.org/10.1200/po-25-00612
ER  -

APA

N, A., Z, S., DS, H., RJ, G., V, W., LM, M., LV, R., DR, P., PM, W., SR, H., N, T., JV, T., BA, C., CL, A., LN, H., PJ, O., AP, C., & KT, F. (2026). Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E.. JCO precision oncology. https://doi.org/10.1200/po-25-00612

Source records

pubmed · retrieved 2026-09-26T13:58:19.455Z